Monday 9 November 2026 Export AGMB’s income statement to Excel — free account

AgomAb Therapeutics NV

AGMB

Healthcare Biotechnology

Insider buying

7.64 0.67 +9.61%

Follow AGMB

Alert me

Market cap: $376.0M
P/E: —
Fwd P/E: —
Dividend yield: —
F-score: n/a
ROIC: 0.00%
Net debt / EBITDA: 2.0×
Dividend safety: n/a

Overview

	Dec '24	Sep '25	Dec '25	Jun '26
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Free Cash Flow per Share Full definition →	—	—	—	0.00
Free Cash Flow Full definition →	—	—	—	(144.00)
Other line items
Cash ROIC Full definition →	0.00%	0.00%	0.00%	(23.90%)
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	—	—	—	0.00
Depreciation/Fixed assets Full definition →	0.00	—	0.00	1.53
Capex/Depreciation Full definition →	—	—	—	0.00
Operating CF per Share Full definition →	—	—	—	0.00

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026